Metabolic network restoration, not donor microbial engraftment, associates with resolution of recurrent Clostridioides difficile infection
Abstract
Fecal microbiota transplantation (FMT) effectively prevents recurrent Clostridioides difficile infection (rCDI). However, the mechanisms underpinning FMT efficacy are incompletely understood. We used proximity-ligation metagenomics, metaproteomics, and metabolomics to profile dynamic changes in rCDI. We analyzed samples collected from the first 7 responders during a clinical trial comparing two donor-based treatments (lyophilized FMT [LFMT] or lyophilized sterile fecal filtrate [LSFF], free of intact microorganisms) to prevent rCDI. LSFF is enriched in Caudoviricetes, lipids, fatty acids, and human and extracellular bacterial proteins compared with LFMT. LFMT recipients had donor microbial engraftment, while LSFF recipients achieved only partial microbial community recovery without donor’s contribution. Our multi-omics analyses identified a functional convergence following both treatments, shifting away from oxidative and antibiotic stress survival pathways toward enhanced carbon-nitrogen utilization pathways, suggesting that FMT mechanisms may involve metabolic reprogramming and host-microbial amino acid co-metabolism. Our findings provide important hypothesis-generating insights that warrant further validation.
Related
- Mechanistic prediction of fecal microbiota transplant engraftment and Clostridioides difficile colonization resistance with μODE
- Culturomics-Guided Precision FMT Enables Stable Antibiotic-Independent Engraftment via Metabolic Niche Targeting
- Over-the-counter fiber supplementation associates with metabolic and microbial shifts in rectal mucosa
- Campylobacter jejuni Infection Is Associated With Cell-Cycle, Redox, and Metabolic Remodeling of Human Intestinal Epithelial Cells at Single-Cell Resolution
- Impact of Host α2-Antiplasmin Deficiency on Engraftment and the Morphological Maturation of Transplanted Neural Precursor Cells in the Mouse Brain
BibTeX
@article{whitman2026metabolic,
title = {{Metabolic network restoration, not donor microbial engraftment, associates with resolution of recurrent Clostridioides difficile infection}},
author = {Brendan T. Whitman and Ramin Karimianghadim and Benjamin Auch and Ivan Liachko and Tanya M. Monaghan and Sepideh Pakpour and Dina Kao},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117907},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03290-6},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Metabolic network restoration, not donor microbial engraftment, associates with resolution of recurrent Clostridioides difficile infection
AU - Brendan T. Whitman
AU - Ramin Karimianghadim
AU - Benjamin Auch
AU - Ivan Liachko
AU - Tanya M. Monaghan
AU - Sepideh Pakpour
AU - Dina Kao
PY - 2026
DA - 2026/10/16
JO - iScience
DO - 10.1016/j.isci.2026.117907
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03290-6
AB - Fecal microbiota transplantation (FMT) effectively prevents recurrent Clostridioides difficile infection (rCDI). However, the mechanisms underpinning FMT efficacy are incompletely understood. We used proximity-ligation metagenomics, metaproteomics, and metabolomics to profile dynamic changes in rCDI. We analyzed samples collected from the first 7 responders during a clinical trial comparing two donor-based treatments (lyophilized FMT [LFMT] or lyophilized sterile fecal filtrate [LSFF], free of intact microorganisms) to prevent rCDI. LSFF is enriched in Caudoviricetes, lipids, fatty acids, and human and extracellular bacterial proteins compared with LFMT. LFMT recipients had donor microbial engraftment, while LSFF recipients achieved only partial microbial community recovery without donor’s contribution. Our multi-omics analyses identified a functional convergence following both treatments, shifting away from oxidative and antibiotic stress survival pathways toward enhanced carbon-nitrogen utilization pathways, suggesting that FMT mechanisms may involve metabolic reprogramming and host-microbial amino acid co-metabolism. Our findings provide important hypothesis-generating insights that warrant further validation.
SN - 2589-0042
ER -